Intracranial Atherosclerosis Clinical Trials

10 recruiting

Frequently Asked Questions

Common questions about Intracranial Atherosclerosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

Intracranial Atherosclerosis
Ton-Bridge Medical Tech. Co., Ltd200 enrolled13 locationsNCT05757505
Recruiting
Phase 2Phase 3

Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

Stroke, IschemicIntracranial Atherosclerosis
National University of Singapore130 enrolled1 locationNCT07282041
Recruiting

MPR for Stroke Risk Assessment of ICAS

ICAS - Intracranial Atherosclerosis
Xuanwu Hospital, Beijing400 enrolled1 locationNCT07309718
Recruiting
Not Applicable

IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS)

StrokeIntracranial AtherosclerosisStroke, Acute Ischemic
University Hospital, Basel, Switzerland498 enrolled1 locationNCT06472336
Recruiting
Not Applicable

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD

Intracranial Atherosclerosis
Sunnybrook Health Sciences Centre100 enrolled2 locationsNCT06714526
Recruiting

Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study

Cognitive ImpairmentCerebrovascular EventIntracranial Atherosclerosis
Anhui Medical University100 enrolled1 locationNCT06336174
Recruiting

High-resolution Magnetic Resonance Imaging of Intracranial Atherosclerotic Plaques in Ischemic Stroke

StrokeIntracranial AtherosclerosisHigh Resolution Magnetic Resonance Imaging
General Hospital of Shenyang Military Region2,110 enrolled1 locationNCT05897645
Recruiting
Phase 4

PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis

Atherosclerotic PlaqueIntracranial AtherosclerosisIntracranial Artery Stenosis
Peking Union Medical College Hospital300 enrolled19 locationsNCT06902740
Recruiting

A Prospective Multicenter Registry Study on BASIS Technique for Endovascular Therapy of Acute Large Vessel Occlusion Strokes Due to Intracranial Atherosclerotic Disease

Acute Ischemic StrokeICAS - Intracranial Atherosclerosis
Fujian Medical University Union Hospital250 enrolled1 locationNCT06881420
Recruiting
Not Applicable

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

StrokeICAD - Intracranial Atherosclerotic DiseaseICAS - Intracranial Atherosclerosis+3 more
Beijing Tiantan Hospital792 enrolled18 locationsNCT04948749
Recruiting

ICAS Screen Based on RIC

Intracranial Atherosclerosis
Xuanwu Hospital, Beijing2,100 enrolled1 locationNCT06610578
Recruiting
Not Applicable

ACOART Intracranial ISR Pilot:Intracranial DCB in the Treatment of Intracranial In-stent Restenosis

StrokeIntracranial Atherosclerosis
Acotec Scientific Co., Ltd20 enrolled1 locationNCT04627870
Recruiting

Feedback Loop Between Intracranial Atherosclerosis and Cerebral Small Vessel Disease

ICAS - Intracranial AtherosclerosisCerebral Small Vessel Diseases
Chinese PLA General Hospital300 enrolled1 locationNCT05677607
Recruiting

Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis

Ischemic StrokeOptical Coherence TomographyIntracranial Atherosclerosis+2 more
jiaoliqun400 enrolled1 locationNCT05550077